Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 2
Emapalumab for the Treatment of Anti-MDA5 Antibody Positive Rapidly Progressive Interstitial Lung Disease
This is a proof of concept study to determine if Emapalumab appears effective for the treatment of anti-MDA5 antibody positive rapidly progressive interstitial…
DermatomyositisDermatomyositis Sine MyositisDermatomyositis With Myopathy+4 more
Estimated
~$10 – $6,250
University of MiamiNCT07486869
Phase 2
A Phase II Study of BIO 300 to Reduce the Toxicity of Thoracic Radiotherapy for Patients With Early-Stage Non-Small Cell Lung Cancer and Interstitial Lung Disease (BREATHE)
The purpose of this study to find out whether giving BIO 300 in combination with thoracic radiation therapy is effective in preventing pneumonitis in people wi…
NSCLCNSCLC, Stage INSCLC Stage II+5 more
Estimated
~$10 – $6,250
Memorial Sloan Kettering Cancer CenterNCT07323732